Table 2 Portal vein embolization (PVE): outcome measures
Patients | Gender | Age | Disease | Segments | FLR-V pre (mL) | FLR-V post (mL) | Increase FLR-V % | TELV pre (Ml) | TELV post (mL) | Embolized lobe-V pre (mL) | Embolized lobe-V post (mL) | FLR-V/ TELV pre (%) | FLR-V/ TELV post (%) | Increase FLR-V/TELV (%) | ASTpre (UI/L) | ALTpre (UI/L) | Bilipre (mg/dL) | ASTpost (UI/L) | ALTpost (UI/L) | Bilipost (mg/dL) | TL-F (%/min/m2) | FLR-F (%/min/m2) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 79 | MTS | RPVE+IVb | 273.4 | 518.7 | 89.72% | 1331.6 | 1230.3 | 1058.2 | 711.6 | 20.53% | 42.16% | 105.34% | 51 | 0.52 | 71 | 61 | 0.72 | 0.72 | / | / |
2 | M | 77 | Cholangio | RPVE | 405.8 | 647.9 | 59.66% | 1462.4 | 1846.1 | 1056.6 | 1198.2 | 27.75% | 35.10% | 26.48% | 28 | 29 | 1.15 | 30 | 40 | 0.74 | / | / |
3 | M | 74 | Cholangio | RPVE | 413.8 | 707.6 | 71.00% | 1439 | 1520.4 | 1025.2 | 812.8 | 28.76% | 46.54% | 61.85% | 165 | 171 | 7.42 | 66 | 78 | 3.72 | / | / |
4 | F | 70 | MTS | RPVE+IV | 245.5 | 371.2 | 51.20% | 1230.6 | 1137.1 | 985.1 | 765.9 | 19.95% | 32.64% | 63.63% | 262 | 111 | 1.55 | 201 | 55 | 4.52 | 2.2 | 1.55 |
5 | M | 79 | HCC | RPVE | 640.7 | 751.7 | 17.32% | 1453.5 | 1313.7 | 812.8 | 562 | 44.08% | 57.22% | 29.81% | 76 | 118 | 1.02 | 52 | 71 | 0.7 | 6.58 | 4.95 |
6 | F | 56 | MTS | RPVE+IV | 647.8 | 813 | 25.50% | 1461.7 | 1332.8 | 813.9 | 519.8 | 44.32% | 61.00% | 37.64% | 164 | 435 | 0.51 | 73 | 235 | 0.6 | 5.15 | 4.1 |
7 | M | 55 | Cholangio | RPVE+I + IV | 360.3 | 504.4 | 39.99% | 1402.3 | 1340.1 | 1042 | 835.7 | 25.69% | 37.64% | 46.49% | 21 | 52 | 0.56 | 16 | 32 | 0.25 | 5.96 | 2.52 |
8 | M | 78 | MTS | RPVE+I + IV | 325.6 | 464.5 | 42.66% | 1374.1 | 1492.9 | 1048.5 | 1028.4 | 23.70% | 31.11% | 31.31% | 41 | 66 | 0.4 | 26 | 27 | 0.9 | 5.47 | 0.44 |
9 | M | 77 | HCC | RPVE | 675.4 | 1099.9 | 62.85% | 1556.5 | 1857.1 | 881.1 | 757.2 | 43.39% | 59.23% | 36.49% | 92 | 44 | 0.75 | 106 | 52 | 1.07 | 4.39 | 2.07 |
10 | F | 55 | Cholangio | RPVE+IV | 356.4 | 610 | 71.16% | 1471.1 | 1750 | 1114.7 | 1140 | 24.23% | 34.86% | 43.88% | 94 | 77 | 1.32 | 23 | 15 | 10.74 | 6.92 | 3.23 |